Article: Nastech to Manufacture Nascobal(R) Nasal Spray for QOL Medical.

BOTHELL, Wash., Oct. 17 /PRNewswire-FirstCall/ -- Nastech Pharmaceutical Company Inc. , a leader in developing therapeutics using advanced molecular biology-based drug delivery technologies, announced today that, following QOL Medical LLC's acquisition of Nascobal(R) (Cyanocobalamin, USP) Nasal Spray for the treatment of vitamin B-12 deficiency from Questcor Pharmaceuticals, Inc. , Nastech will be the exclusive manufacturer of the product for QOL Medical.

QOL Medical has assumed the rights and obligations of the asset purchase agreement and the separate supply agreement made with Questcor in June 2003 with certain modifications agreed upon by both parties, which ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!